{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Menon U"],"funding":["Cancer Research UK","Medical Research Council","National Institute for Health Research (NIHR)"],"pagination":["1018-1028"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7616829"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(9)"],"pubmed_abstract":["Background
In UKCTOCS, there was a decrease in the diagnosis of advanced stage tubo-ovarian cancer but no reduction in deaths in the multimodal screening group compared with the no screening group. Therefore, we did exploratory analyses of patients with high-grade serous ovarian cancer to understand the reason for the discrepancy.Methods
UKCTOCS was a 13-centre randomised controlled trial of screening postmenopausal women from the general population, aged 50-74 years, with intact ovaries. The trial management system randomly allocated (2:1:1) eligible participants (recruited from April 17, 2001, to Sept 29, 2005) in blocks of 32 using computer generated random numbers to no screening or annual screening (multimodal screening or ultrasound screening) until Dec 31, 2011. Foll"],"journal":["The Lancet. Oncology"],"pubmed_title":["Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial."],"pmcid":["PMC7616829"],"funding_grant_id":["CL-2009-18-006","G0801228","16/46/01","MC_UU_12023/28","MC_UU_00004/01","G9901012"],"pubmed_authors":["Burnell M","Campbell S","Jacobs IJ","Parmar MKB","McGuire AJ","Menon U","Ryan A","Kalsi JK","Arora R","Sharma A","Dawnay A","Singh N","Gentry-Maharaj A","Woolas R","Williamson K","Casey L","Apostolidou S","Skates SJ","Manchanda R","Fallowfield L"],"additional_accession":[]},"is_claimable":false,"name":"Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.","description":"Background
In UKCTOCS, there was a decrease in the diagnosis of advanced stage tubo-ovarian cancer but no reduction in deaths in the multimodal screening group compared with the no screening group. Therefore, we did exploratory analyses of patients with high-grade serous ovarian cancer to understand the reason for the discrepancy.Methods
UKCTOCS was a 13-centre randomised controlled trial of screening postmenopausal women from the general population, aged 50-74 years, with intact ovaries. The trial management system randomly allocated (2:1:1) eligible participants (recruited from April 17, 2001, to Sept 29, 2005) in blocks of 32 using computer generated random numbers to no screening or annual screening (multimodal screening or ultrasound screening) until Dec 31, 2011. Foll","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Sep","modification":"2026-06-03T00:19:15.723Z","creation":"2025-04-06T17:30:13.147Z"},"accession":"S-EPMC7616829","cross_references":{"pubmed":["37657461"],"doi":["10.1016/S1470-2045(23)00335-2"]}}